Harmonic Discovery

Multi-targeted therapeutics to treat complex diseases

New York, United States · Founded 2021 · $8.0M raised

Headquarters
New York, New York
Employees
1–10
Founded
2021
Total Funding
$8.0M
Last Round
$8.0M SeedSep 2022
Rounds
1

About

We are a drug discovery company developing a new generation of therapeutics that embrace the complexity of disease. Currently available approaches for creating drugs work on the principle of finding one drug-one protein 'magic bullets'. However, diseases such as cancer and autoimmunity are often the result of several dysregulated proteins across many distinct biological pathways. We are building a computational-experimental platform to design therapeutics that can target several disease-causing proteins at once. By designing multi-specific drugs, we are able to create therapeutics that are more efficacious and safer than existing medicines.

Summary

Harmonic Discovery is a Biotech company based in New York, United States, founded in 2021. It has raised $8.0M in total across 1 round, most recently a $8.0M Seed round in Sep 2022. Investors include Innovation Endeavors and Boom Capital.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

SeedSeed RoundSep 2022
$8.0M

Investors

Similar Companies